carbogen has been researched along with carmustine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ara, G; Ha, CS; Herman, TS; Holden, SA; Northey, D; Teicher, BA | 1 |
| Herman, TS; Hopkins, RE; Menon, K; Teicher, BA | 1 |
| Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
| Holden, SA; Rose, CM; Teicher, BA | 1 |
| Evans, RG; Kimler, BF; Martin, DF; Morantz, RA; Vats, TS | 1 |
| Bernal, SD; Cathcart, KN; Holden, SA; Teicher, BA | 1 |
| Herman, TS; Rose, CM; Teicher, BA | 1 |
7 other study(ies) available for carbogen and carmustine
| Article | Year |
|---|---|
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
Topics: Administration, Inhalation; Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Carbon Dioxide; Carmustine; Cell Survival; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Emulsions; Fibrosarcoma; Fluorocarbons; Hematopoietic Stem Cells; Hydrocarbons, Brominated; Male; Melphalan; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Oxygen; Tumor Cells, Cultured | 1992 |
Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
Topics: Alkylating Agents; Animals; Carbon Dioxide; Carmustine; Cattle; Cisplatin; Cyclophosphamide; Drug Synergism; Fibrosarcoma; Hemoglobins; Male; Melphalan; Mice; Mice, Inbred C3H; Oxygen | 1992 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
Topics: Animals; Bone Marrow; Carbon Dioxide; Carmustine; Cell Survival; Drug Combinations; Fibrosarcoma; Fluorocarbons; Hydroxyethyl Starch Derivatives; Lomustine; Male; Mice; Mice, Inbred C3H; Nitrosourea Compounds; Oxygen; Semustine | 1986 |
Potentiation of rat brain tumor therapy by fluosol and carbogen.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carbon Dioxide; Carmustine; Combined Modality Therapy; Fluorocarbons; Hypoxia; Male; Oxygen; Rats; Rats, Inbred F344 | 1988 |
Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carmustine; Cell Division; Cell Survival; Drug Combinations; Etoposide; Fluorocarbons; Hydroxyethyl Starch Derivatives; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Organoplatinum Compounds; Oxygen | 1988 |
Effect of Fluosol-DA on the response of intracranial 9L tumors to X rays and BCNU.
Topics: Administration, Inhalation; Animals; Brain Neoplasms; Carbon Dioxide; Carmustine; Combined Modality Therapy; Drug Combinations; Fluorocarbons; Glioma; Hydroxyethyl Starch Derivatives; Male; Neoplasm Transplantation; Oxygen; Rats; Rats, Inbred F344 | 1988 |